(1-(Tert-butoxycarbonyl)-1H-indol-5-yl)boronic acid, 97%, 1g

Ethyl 3-(3-aminobenzamido)benzoate, 95%, 100mg

(S)-(+)-DBD-Py-NCS [=(S)-(+)-4-(N,N-Dimethylaminosulfonyl)-7-(3-isothiocyanatopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [for HPLC Labeling]>98.0%(HPLC)500mg

(2S,4S)-1-ISOPROPYL-4-METHOXY-PROLINE, 97.0%, 1g

Ethyl [2,2':6',2''-terpyridine]-4'-carboxylate, 98%, 1g

(2R,3R)-N-((1S,2R)-1-HYDROXY-1-PHENYLPROPAN-2-YL)-3-METHOXY-2-METHYL-3-((S)-PYRROLIDIN-2-YL)PROPANAMIDE (HCL), 98%, 250mg

Methyl 6-bromo-3-oxo-3,4-dihydropyrazine-2-carboxylate, 98%, 1g

(S)-2-(4-Chlorophenyl)-3-methylbutanoic acid, 95.0%, 10g

(2E)-1-(4-ethoxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one, 95.0%, 10g

8-(Trifluoromethyl)quinolin-6-amine, 98%, 100mg

ETHYL 6-BROMOIMIDAZO[1,2-A]PYRIMIDINE-3-CARBOXYLATE, 95.0%, 100mg

8-Bromo-4-chloropyrido[4,3-d]pyrimidine, 98%, 100mg

(2-Bromo-5-(trifluoromethyl)phenyl)(4-methylpiperazin-1-yl)methanone, 98%, 1g